These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28450563)

  • 1. SSTR-Mediated Imaging in Breast Cancer: Is There a Role for Radiolabeled Somatostatin Receptor Antagonists?
    Dalm SU; Haeck J; Doeswijk GN; de Blois E; de Jong M; van Deurzen CHM
    J Nucl Med; 2017 Oct; 58(10):1609-1614. PubMed ID: 28450563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Therapeutic Response to Treatment with a 177Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models.
    Dalm SU; Nonnekens J; Doeswijk GN; de Blois E; van Gent DC; Konijnenberg MW; de Jong M
    J Nucl Med; 2016 Feb; 57(2):260-5. PubMed ID: 26514177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal Imaging of 2-Cycle PRRT with
    Albrecht J; Exner S; Grötzinger C; Prasad S; Konietschke F; Beindorff N; Kühl AA; Prasad V; Brenner W; Koziolek EJ
    J Nucl Med; 2021 Mar; 62(3):393-398. PubMed ID: 32859703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution, Pharmacokinetics, and Dosimetry of
    Nicolas GP; Mansi R; McDougall L; Kaufmann J; Bouterfa H; Wild D; Fani M
    J Nucl Med; 2017 Sep; 58(9):1435-1441. PubMed ID: 28450554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin Receptor Antagonists for Imaging and Therapy.
    Fani M; Nicolas GP; Wild D
    J Nucl Med; 2017 Sep; 58(Suppl 2):61S-66S. PubMed ID: 28864614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.
    Dalm SU; Martens JW; Sieuwerts AM; van Deurzen CH; Koelewijn SJ; de Blois E; Maina T; Nock BA; Brunel L; Fehrentz JA; Martinez J; de Jong M; Melis M
    J Nucl Med; 2015 May; 56(5):752-7. PubMed ID: 25791989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 177Lu-DOTA-sst2 antagonist versus 177Lu-DOTA-sst2 agonist binding in human cancers in vitro.
    Cescato R; Waser B; Fani M; Reubi JC
    J Nucl Med; 2011 Dec; 52(12):1886-90. PubMed ID: 22068898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Biological Evaluation of
    Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z
    Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallium-68 labeled somatostatin receptor antagonist PET/CT in over 500 patients with neuroendocrine neoplasms: experience from a single center in China.
    Liu M; Cheng Y; Bai C; Zhao H; Jia R; Chen J; Zhu W; Huo L
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2002-2011. PubMed ID: 38337073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of a
    Radford L; Gallazzi F; Watkinson L; Carmack T; Berendzen A; Lewis MR; Jurisson SS; Papagiannopoulou D; Hennkens HM
    Nucl Med Biol; 2017 Apr; 47():4-9. PubMed ID: 28043006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model.
    Rylova SN; Stoykow C; Del Pozzo L; Abiraj K; Tamma ML; Kiefer Y; Fani M; Maecke HR
    PLoS One; 2018; 13(4):e0195802. PubMed ID: 29668724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected sensitivity of sst2 antagonists to N-terminal radiometal modifications.
    Fani M; Braun F; Waser B; Beetschen K; Cescato R; Erchegyi J; Rivier JE; Weber WA; Maecke HR; Reubi JC
    J Nucl Med; 2012 Sep; 53(9):1481-9. PubMed ID: 22851637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor targeting with hydrophilic [
    Makris G; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
    Nucl Med Biol; 2019 Apr; 71():39-46. PubMed ID: 31129499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of agonist and antagonist radioligands for somatostatin receptor imaging of breast cancer using positron emission tomography.
    Dude I; Zhang Z; Rousseau J; Hundal-Jabal N; Colpo N; Merkens H; Lin KS; Bénard F
    EJNMMI Radiopharm Chem; 2017; 2(1):4. PubMed ID: 29503845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft Models.
    Zhang L; Vines DC; Scollard DA; McKee T; Komal T; Ganguly M; Do T; Wu B; Alexander N; Vali R; Shammas A; Besanger T; Baruchel S
    Contrast Media Mol Imaging; 2017; 2017():9481276. PubMed ID: 29097943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fundamental study of radiogallium-labeled aspartic acid peptides introducing octreotate derivatives.
    Ishizaki A; Mishiro K; Shiba K; Hanaoka H; Kinuya S; Odani A; Ogawa K
    Ann Nucl Med; 2019 Apr; 33(4):244-251. PubMed ID: 30604401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative biodistributions and dosimetry of [¹⁷⁷Lu]DOTA-anti-bcl-2-PNA-Tyr³-octreotate and [¹⁷⁷Lu]DOTA-Tyr³-octreotate in a mouse model of B-cell lymphoma/leukemia.
    Balkin ER; Liu D; Jia F; Ruthengael VC; Shaffer SM; Miller WH; Lewis MR
    Nucl Med Biol; 2014 Jan; 41(1):36-42. PubMed ID: 24267052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of somatostatin receptor agonist and antagonist for peptide receptor radionuclide therapy: a pilot study.
    Wild D; Fani M; Fischer R; Del Pozzo L; Kaul F; Krebs S; Fischer R; Rivier JE; Reubi JC; Maecke HR; Weber WA
    J Nucl Med; 2014 Aug; 55(8):1248-52. PubMed ID: 24963127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer imaging using radiolabelled somatostatin analogues.
    Dalm SU; Melis M; Emmering J; Kwekkeboom DJ; de Jong M
    Nucl Med Biol; 2016 Sep; 43(9):559-565. PubMed ID: 27409729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.
    Ginj M; Zhang H; Waser B; Cescato R; Wild D; Wang X; Erchegyi J; Rivier J; Mäcke HR; Reubi JC
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16436-41. PubMed ID: 17056720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.